Cargando…
Nanoscopic Assessment of Anti-SARS-CoV-2 Spike Neutralizing Antibody Using High-Speed AFM
[Image: see text] Anti-spike neutralizing antibodies (S NAbs) have been developed for prevention and treatment against COVID-19. The nanoscopic characterization of the dynamic interaction between spike proteins and S NAbs remains difficult. By using high-speed atomic force microscopy (HS-AFM), we el...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881159/ https://www.ncbi.nlm.nih.gov/pubmed/36641798 http://dx.doi.org/10.1021/acs.nanolett.2c04270 |
_version_ | 1784879054436958208 |
---|---|
author | Lim, Keesiang Nishide, Goro Sajidah, Elma Sakinatus Yamano, Tomoyoshi Qiu, Yujia Yoshida, Takeshi Kobayashi, Akiko Hazawa, Masaharu Ando, Toshio Hanayama, Rikinari Wong, Richard W. |
author_facet | Lim, Keesiang Nishide, Goro Sajidah, Elma Sakinatus Yamano, Tomoyoshi Qiu, Yujia Yoshida, Takeshi Kobayashi, Akiko Hazawa, Masaharu Ando, Toshio Hanayama, Rikinari Wong, Richard W. |
author_sort | Lim, Keesiang |
collection | PubMed |
description | [Image: see text] Anti-spike neutralizing antibodies (S NAbs) have been developed for prevention and treatment against COVID-19. The nanoscopic characterization of the dynamic interaction between spike proteins and S NAbs remains difficult. By using high-speed atomic force microscopy (HS-AFM), we elucidate the molecular property of an S NAb and its interaction with spike proteins. The S NAb appeared as monomers with a Y conformation at low density and formed hexameric oligomers at high density. The dynamic S NAb–spike protein interaction at RBD induces neither RBD opening nor S1 subunit shedding. Furthermore, the interaction was stable at endosomal pH. These findings indicated that the S NAb could have a negligible risk of antibody-dependent enhancement. Dynamic movement of spike proteins on small extracellular vesicles (S sEV) resembled that on SARS-CoV-2. The sensitivity of variant S sEVs to S NAb could be evaluated using HS-AFM. Altogether, we demonstrate a nanoscopic assessment platform for evaluating the binding property of S NAbs. |
format | Online Article Text |
id | pubmed-9881159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-98811592023-01-28 Nanoscopic Assessment of Anti-SARS-CoV-2 Spike Neutralizing Antibody Using High-Speed AFM Lim, Keesiang Nishide, Goro Sajidah, Elma Sakinatus Yamano, Tomoyoshi Qiu, Yujia Yoshida, Takeshi Kobayashi, Akiko Hazawa, Masaharu Ando, Toshio Hanayama, Rikinari Wong, Richard W. Nano Lett [Image: see text] Anti-spike neutralizing antibodies (S NAbs) have been developed for prevention and treatment against COVID-19. The nanoscopic characterization of the dynamic interaction between spike proteins and S NAbs remains difficult. By using high-speed atomic force microscopy (HS-AFM), we elucidate the molecular property of an S NAb and its interaction with spike proteins. The S NAb appeared as monomers with a Y conformation at low density and formed hexameric oligomers at high density. The dynamic S NAb–spike protein interaction at RBD induces neither RBD opening nor S1 subunit shedding. Furthermore, the interaction was stable at endosomal pH. These findings indicated that the S NAb could have a negligible risk of antibody-dependent enhancement. Dynamic movement of spike proteins on small extracellular vesicles (S sEV) resembled that on SARS-CoV-2. The sensitivity of variant S sEVs to S NAb could be evaluated using HS-AFM. Altogether, we demonstrate a nanoscopic assessment platform for evaluating the binding property of S NAbs. American Chemical Society 2023-01-15 /pmc/articles/PMC9881159/ /pubmed/36641798 http://dx.doi.org/10.1021/acs.nanolett.2c04270 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Lim, Keesiang Nishide, Goro Sajidah, Elma Sakinatus Yamano, Tomoyoshi Qiu, Yujia Yoshida, Takeshi Kobayashi, Akiko Hazawa, Masaharu Ando, Toshio Hanayama, Rikinari Wong, Richard W. Nanoscopic Assessment of Anti-SARS-CoV-2 Spike Neutralizing Antibody Using High-Speed AFM |
title | Nanoscopic
Assessment of Anti-SARS-CoV-2 Spike
Neutralizing Antibody Using High-Speed AFM |
title_full | Nanoscopic
Assessment of Anti-SARS-CoV-2 Spike
Neutralizing Antibody Using High-Speed AFM |
title_fullStr | Nanoscopic
Assessment of Anti-SARS-CoV-2 Spike
Neutralizing Antibody Using High-Speed AFM |
title_full_unstemmed | Nanoscopic
Assessment of Anti-SARS-CoV-2 Spike
Neutralizing Antibody Using High-Speed AFM |
title_short | Nanoscopic
Assessment of Anti-SARS-CoV-2 Spike
Neutralizing Antibody Using High-Speed AFM |
title_sort | nanoscopic
assessment of anti-sars-cov-2 spike
neutralizing antibody using high-speed afm |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881159/ https://www.ncbi.nlm.nih.gov/pubmed/36641798 http://dx.doi.org/10.1021/acs.nanolett.2c04270 |
work_keys_str_mv | AT limkeesiang nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm AT nishidegoro nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm AT sajidahelmasakinatus nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm AT yamanotomoyoshi nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm AT qiuyujia nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm AT yoshidatakeshi nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm AT kobayashiakiko nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm AT hazawamasaharu nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm AT andotoshio nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm AT hanayamarikinari nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm AT wongrichardw nanoscopicassessmentofantisarscov2spikeneutralizingantibodyusinghighspeedafm |